Australian health advisory on counterfeit Abhayrab is "over-cautionary" and "misplaced", says IIL: Our Bureau, New Delhi Monday, December 29, 2025, 10:00 Hrs [IST] Hyderabad-based ...

IPC to host 36th Skill Development Programme on Pharmacovigilance from 9 to 13 March 2026: Shardul Nautiyal, Mumbai Monday, December 29, 2025, 09:00 Hrs [IST] The Indian Pharmacop ...

Peethaambaran Kunnathoor, Chennai Monday, December 29, 2025, 08:00 Hrs [IST] ...

NPPA to allow Serum Institute to discontinue manufacturing of two pack sizes of TT vaccine: Gireesh Babu, New Delhi Monday, December 29, 2025, 08:00 Hrs [IST] The National Pharmac ...

Panel asks Ministry of Ayush to improve support related to cultivation of medicinal plants: Gireesh Babu, New Delhi Monday, December 29, 2025, 08:00 Hrs [IST] The Parliamentary Pa ...

Experts discuss Indian pharmaceutical strategic roadmap for 2026: Shardul Nautiyal, Mumbai Monday, December 29, 2025, 08:00 Hrs [IST] Indian pharmaceutical companies have a golden ...

Indian healthcare sector fuels rapid tech expansion with robust private capital infusion: Nandita Vijayasimha, Bengaluru Monday, December 29, 2025, 08:00 Hrs [IST] Indian healthca ...

Singlera Genomics inks research and distribution agreement with Pure Medical for cancer detection products: La Jolla, California Saturday, December 27, 2025, 13:00 Hrs [IST] Singl ...

Seongnam, South Korea Saturday, December 27, 2025, 17:00 Hrs [IST] ...

Next Gen Diagnostics introduces NGD Infection Prevention to provide real-time transmission detection: Cambridge, Massachusetts Saturday, December 27, 2025, 18:00 Hrs [IST] Next Ge ...

Nandita Vijayasimha, Bengaluru Friday, December 26, 2025, 08:00 Hrs [IST] ...

Daiichi Sankyo &AstraZeneca’s Enhertu approved in China as first HER2 directed medicine for patients with HER2 low or HER2 ultralow metastatic breast cancer ...